STRYKER CORPORATIONUnderwriting Agreement • September 16th, 2011 • Stryker Corp • Surgical & medical instruments & apparatus • New York
Introductory. Stryker Corporation, a Michigan corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”), acting severally and not jointly, the respective amounts set forth in such Schedule A of $750,000,000 aggregate principal amount of the Company’s 2.00% Notes due 2016 (the “Notes”). Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Notes.
Stryker Corporation and as Trustee Third Supplemental Indenture Dated as of September 16, 2011 to Senior Debt Indenture Dated as of January 15, 2010 Establishing a series of Securities designatedThird Supplemental Indenture • September 16th, 2011 • Stryker Corp • Surgical & medical instruments & apparatus • New York
THIRD SUPPLEMENTAL INDENTURE, dated as of September 16, 2011 (this “Third Supplemental Indenture”) between Stryker Corporation, a corporation duly organized and existing under the laws of the State of Michigan (herein called the “Company”), having its principal office at 2825 Airview Boulevard, Kalamazoo, Michigan, and U.S. Bank National Association, a nationally chartered banking association, as trustee (herein called the “Trustee”).
